Impaired telomerase activity in uninfected haematopoietic progenitors in HIV-1-infected patients

AIDS

Volumn 12, Issue 9, 1998, Pages 999-1005

  Vignoli, Monica ^a   Stecca, Barbara ^b   Furlini, Giuliano ^a   Re, Maria Carla ^a   Mantovani, Vilma ^b   Zauli, Giorgio ^c   Visani, Giuseppe ^a   Colangeli, Vincenzo ^a   La Placa, Michele ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

gp120; Haematopoietic progenitor cells; HIV 1 infection; Telomerase; Transforming growth factor 1

Indexed keywords

CD34 ANTIGEN; GLYCOPROTEIN GP 120; TELOMERASE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL;

EID: 0032543537     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199809000-00006     Document Type: Article

References (37)

1. Zauli G, Davis BR: Role of HIV infection in the hematologic manifestations of HIV seropositive subjects. Crit Rev Oncol Hematol 1993, 15:271-283.
2. Re MG, Furlini G, Zauli G, La Placa M: Human immunodeficiency virus type 1 (HIV-1) and human hematopoietic progenitors. Brief review. Arch Virol 1994, 137:1-23.
3. Zauli G, Re MC, Davis B, et al.: Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals. Blood 1992, 79:2680-2687.
4. Zauli G, Re MC, Furlini G, Giovannini M, La Plata M: Human immunodeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human hematopoietic progenitors (CD34+ cells). J Gen Virol 1992, 73:417-421.
5. Re MC, Zauli G, Gibellini D, et al.: Uninfected hematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture. AIDS 1993, 7:1049-1055.
6. Zauli G, Vitale M, Re MC, et al.: In vitro exposure to human immunodeficiency virus type 1 induces apoptotic death of the factor-dependent TF-1 hematopoietic cell line. Blood 1994, 83:167-175.
7. Zauli G, Furlini G, Vitale M, et al.: A subset of human CD34+ hematopoietic progenitors express low levels of CD4, the high-affinity receptor for human immunodeficiency virus type 1. Blood 1994, 84:1896-1905.
8. Louache F, Debili N, Marandin A, Coulombel L, Vainchenker W: Expression of CD4 by human hematopoietic progenitors. Blood 1994, 84:3344-3355.
9. Zauli G, Vitale M, Cibellini D, Capitani S: Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor β1. J Exp Med 1996, 183:99-108.
10. Gibellini D, Celeghini C, Panaya R, et al.: The engagement of CD4 surface antigen in the HEL haematopoietic cell line up-regulates the transforming growth factor-β1 (TCF-β1) promoter activity. Br J Haematol 1997, 97:571-578.
11. Lardon F, Snoeck HW, Nijs G, et al.: Transforming growth factor-β regulates the cell cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor, or IL-6 stimulated CD34+ human hematopoietic progenitor cells through different kinetic mechanisms depending on the applied stimulus. Exp Hematol 1994, 22:903-909.
12. Li CY, Suardet L, Littel JB: Potential role of WAF1/Cip1/p21 as mediator of TGF-beta cytoinhibitory effect. J Biol Chem 1995, 270:4971-4974.
13. Selvakumaran M, Lin HK, Miyashita T, et al.: Immediate early up-regulation of bax expression by p53 but not TCFβ1: a paradigm for distinct apoptotic pathways. Oncogene 1994, 9:1791-1798.
14. Zhu X, Kumar R, Mandai M, et al.: Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci USA 1996, 93:6091-6095.
15. Blackburn EH: Structure and function of telomeres. Nature 1991, 350:569-573.
16. Greider CW: Telomere length regulation. Annu Rev Biochem 1996, 65:337-365.
17. Harley CB, Kim NW, Prowse KR, et al.: Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 1994, LVIX:307-315.
18. Blasco MA, Lee H-W, Hande MP, et al.: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997, 91:25-34.
19. Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL: The aging of hematopoietic stem cells. Nature Med 1996, 2:1011-1016.
20. Chiu CP, Dragowska K, Kim NW, et al.: Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 1996, 14:239-248.
21. Hiyama K, Hirai Y, Kyaizumi S, et al.: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995, 155:3711-3715.
22. Sutherland DR, Keating A, Nayar R, et al.: Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994, 22:1003-1010.
23. Tong J, Hoffman R, Siena S, et al.: Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autographs. Exp Hematol 1994, 22:1016-1024.
24. de Wynter EA, Coutinho LH, Pei X, et al.: Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems. Stem Cells 1995, 13:524-532.
25. Kim NW, Piatyszek MA, Prowse KR, et al.: Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
26. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Wright WE, Shay JW: Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 1994, 17:1-15.
27. Centers for Disease Control: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41:1-19.
28. Effros RB, Allsopp R, Chiu C-P, et al.: Shortened telomeres in the expanded CD28- CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996, 10:F17-F22.
29. Palmer LD, Weng N-P, Levine BL, June CH, Lane CH, Hodes RJ: Telomere length, telomerase activity, and replicative potential in HIV infection: analysis of CD4- and CD8+ T cells from HIV-discordant monozygotic twins. J Exp Med 1997, 185:1381-1386.
30. Pommier JP, Gauthier L, Livartowski J, et al.: Immunosenescence in HIV pathogenesis. Virology 1997, 231:148-154.
31. Broccoli D, Young JW, De Lange T: Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995, 92:9082-9086.
32. Vaziri H, Dragowska W, Allsopp RC, Thomas TT, Harley CB, Lansdorp PM: Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994, 91:9857-9860.
33. Bagnara GP, Zauli G, Giovannini M, Re MC, Furlini G, La Placa M: Early loss of circulating hematopoietic progenitors in HIV-1-infected subjects. Exp Hematol 1990, 18:426-430.
34. Re MC, Zauli G, Furlini G, et al.: The impaired number of circulating granulocyte macrophage progenitors (CFU-GM) in human immunodeficiency virus type 1 infected subjects correlates with an active HIV-1 replication. Arch Virol 1993, 129:53-64.
35. Strahl C, Blackburn EH: The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena. Nucleic Acid Res 1994, 22:893-900.
36. Strahl C, Blackburn EH: Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized cell lines. Mol Cell Biol 1996, 16:53-65.
37. Yegorov YE, Chernov DN, Akimov SS, Bolsheva NL, Krayeska AA, Zelenin AV: Reverse transcriptase inhibitors suppress telomerase function and induce senescence-like processes in cultured mouse fibroblasts. FEBS Lett 1996, 389:115-118.